 Calmette-Guerin immunization infants mothers prospective follow-up babies risk perinatal infection mothers seropositive control babies mothers seronegative occurrence complications bacillus Calmette-Guerin BCG immunization ability cutaneous reactivity Babies mothers BCG immunization first month life Expanded Programme Immunization EPI recommendations Local regional complications BCG vaccine months inoculation tuberculin skin test months age babies mothers infected uninfected clinical condition serological status months age mean duration follow-up months months chronic deep ulcerations site injection forms BCG infection frequency BCG-related lymphadenitis group children group uninfected children test contrast tuberculin skin test responses positive group children uninfected group test BCG vaccine safe infected babies continuation BCG immunization policies EPI justified view incidence tuberculosis complication HIV infection